- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $474M
- 1 Form D · Jan 2023
- 45 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 15 granted · 25 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $474,356,988 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1909 | CONCENTRIS SYSTEMS LLC | — | — |
| 1910 | CLAIRWAYS LLC | — | — |
| 1911 | Nine Continents Medical Inc | — | — |
| 1912 | Neumora Therapeutics | — | $474M |
| 1913 | Sanguine Diagnostics And Therapeutics, Inc. | — | — |
| 1914 | GUANINE, INC. | — | — |
| 1915 | Advanced Biosensors Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Paul BernsDirector · Executive Officer
- Kristina BurowDirector
- Matthew FustDirector
- Alaa HalawaDirector
- Maykin HoDirector
- Robert NelsenDirector
- Joshua PintoExecutive Officer
- Kari StefanssonDirector
- Tamara TompkinsExecutive Officer
- Stacie WeningerDirector
Patents
- Predicting The Outcome Of A Clinical Trial Using A Machine Learning Modelgranted
- Methods Of Treating Neurological Disordersapplication
- Generating And Querying Biological Data Graphs Using Machine Learning Modelsapplication
- Identifying Core Patients In Patient Clusters Using Machine Learningapplication
- Modulators Of NLRP3 Inflammasome And Related Products And Methodsapplication
- Modulators Of NLRP3 Inflammasome And Related Products And Methodsapplication
- Methods Of Treating Neurological Disordersgranted
- 1-(2,6-DIAZASPIRO[3.3]HEPTAN-6-YL)-5,6-DIHYDRO-4H-BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE Derivatives And Related Compounds As Vasopressin Antagonists For The Treatment Of Neuro-psychological Disordersgranted
- Pyridazine Derivatives As Modulators Of NLRP3 Inflammasome And Related Methodsapplication
- System And Method Of Facial Analysisgranted
- Crystalline Salt Forms Of Kappa Opioid Receptor Antagonist And Products And Methods Related Theretogranted
- Systems And Methods For Detecting Anxiety Using Eegapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.